Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vyanka Mezcord

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Antibiotics (Basel, Switzerland)|August 28, 2025
Antimicrobial Activity of <i>Lacticaseibacillus rhamnosus</i> CRL 2244 Extracts Against Community- and Hospital-Acquired <i>Staphylococcus aureus</i>Cecilia Rodriguez, Briea Gasca, Vyanka Mezcord, et al.
Biomedicines|February 25, 2023
The Iron Content of Human Serum Albumin Modulates the Susceptibility of <i>Acinetobacter baumannii</i> to CefiderocolJenny Escalante, Brent Nishimura, Marisel R Tuttobene, et al.
Microbiology Spectrum|August 20, 2024
Hetero-antagonism of avibactam and sulbactam with cefiderocol in carbapenem-resistant <i>Acinetobacter</i> sppOlivia Wong, Vyanka Mezcord, Christina Lopez, et al.
Biorxiv : the Preprint Server for Biology|March 18, 2024
Hetero-antagonism of avibactam and sulbactam with cefiderocol in carbapenem-resistant <i>Acinetobacter</i> sppOlivia Wong, Vyanka Mezcord, Christina Lopez, et al.
The Journal of Infectious Diseases|November 12, 2025
Ampicillin/Sulbactam in Combination with Ceftazidime/Avibactam against Metallo-β-Lactamase-Producing Carbapenem-Resistant Acinetobacter baumannii: A Genomics-Informed Mechanism-Based ModelBhavatharini Arun, Eloise Liu, Quentin Vallé, et al.
Journal of Microbiological Methods|June 13, 2024
Comparison of available methods to evaluate cefiderocol susceptibility in Acinetobacter sppFernando Pasteran, Olivia Wong, Vyanka Mezcord, et al.
Scientific Reports|May 24, 2022
Acinetobacter baumannii response to cefiderocol challenge in human urineBrent Nishimura, Jenny Escalante, Marisel R Tuttobene, et al.
Antibiotics (Basel, Switzerland)|August 28, 2025
Spontaneous Emergence of Cefiderocol Resistance in <i>Klebsiella pneumoniae</i> KPC-163: Genomic and Transcriptomic InsightsIrene Luu, Vyanka Mezcord, Jenny Escalante, et al.
Research Square|October 4, 2023
Increased AID Results in Mutations at the CRLF2 Locus Implicated in Latin American ALL Health DisparitiesNicholas Pannunzio, Valeria Rangel, Jason Sterrenberg, et al.
International Journal of Molecular Sciences|July 29, 2023
Induced Heteroresistance in Carbapenem-Resistant <i>Acinetobacter baumannii</i> (CRAB) via Exposure to Human Pleural Fluid (HPF) and Its Impact on Cefiderocol SusceptibilityVyanka Mezcord, Jenny Escalante, Brent Nishimura, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Antibiotics (Basel, Switzerland)|August 28, 2025
Antimicrobial Activity of <i>Lacticaseibacillus rhamnosus</i> CRL 2244 Extracts Against Community- and Hospital-Acquired <i>Staphylococcus aureus</i>Cecilia Rodriguez, Briea Gasca, Vyanka Mezcord, et al.
Biomedicines|February 25, 2023
The Iron Content of Human Serum Albumin Modulates the Susceptibility of <i>Acinetobacter baumannii</i> to CefiderocolJenny Escalante, Brent Nishimura, Marisel R Tuttobene, et al.
Microbiology Spectrum|August 20, 2024
Hetero-antagonism of avibactam and sulbactam with cefiderocol in carbapenem-resistant <i>Acinetobacter</i> sppOlivia Wong, Vyanka Mezcord, Christina Lopez, et al.
Biorxiv : the Preprint Server for Biology|March 18, 2024
Hetero-antagonism of avibactam and sulbactam with cefiderocol in carbapenem-resistant <i>Acinetobacter</i> sppOlivia Wong, Vyanka Mezcord, Christina Lopez, et al.
The Journal of Infectious Diseases|November 12, 2025
Ampicillin/Sulbactam in Combination with Ceftazidime/Avibactam against Metallo-β-Lactamase-Producing Carbapenem-Resistant Acinetobacter baumannii: A Genomics-Informed Mechanism-Based ModelBhavatharini Arun, Eloise Liu, Quentin Vallé, et al.
Journal of Microbiological Methods|June 13, 2024
Comparison of available methods to evaluate cefiderocol susceptibility in Acinetobacter sppFernando Pasteran, Olivia Wong, Vyanka Mezcord, et al.
Scientific Reports|May 24, 2022
Acinetobacter baumannii response to cefiderocol challenge in human urineBrent Nishimura, Jenny Escalante, Marisel R Tuttobene, et al.
Antibiotics (Basel, Switzerland)|August 28, 2025
Spontaneous Emergence of Cefiderocol Resistance in <i>Klebsiella pneumoniae</i> KPC-163: Genomic and Transcriptomic InsightsIrene Luu, Vyanka Mezcord, Jenny Escalante, et al.
Research Square|October 4, 2023
Increased AID Results in Mutations at the CRLF2 Locus Implicated in Latin American ALL Health DisparitiesNicholas Pannunzio, Valeria Rangel, Jason Sterrenberg, et al.
International Journal of Molecular Sciences|July 29, 2023
Induced Heteroresistance in Carbapenem-Resistant <i>Acinetobacter baumannii</i> (CRAB) via Exposure to Human Pleural Fluid (HPF) and Its Impact on Cefiderocol SusceptibilityVyanka Mezcord, Jenny Escalante, Brent Nishimura, et al.
Pageof 2